Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.

Article  PubMed  Google Scholar 

Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, Li WF, Tang LL, Zhou GQ, Zhang Y, et al. Association of Intratumoral Microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol. 2022;8(9):1301–9.

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015;51(17):2587–95.

Article  PubMed  Google Scholar 

Lu T, Xu H, Huang W, Zong J, Pan C, Huang C, Xiao Y, Chen B, Li J, Pan J, et al. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach. Radiother Oncol. 2023;185:109716.

Article  PubMed  Google Scholar 

Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890.

Article  PubMed  Google Scholar 

Meng K, Tey J, Ho FCH, Asim H, Cheo T. Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively. BMC Cancer. 2020;20(1):193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu ZJ, Liu T, Lin JY, Pei ST, Guo L, Liu SL, Mai HQ. Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2023;183:109635.

Article  PubMed  Google Scholar 

Tang LQ, Chen QY, Fan W, Liu H, Zhang L, Guo L, Luo DH, Huang PY, Zhang X, Lin XP, et al. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31(23):2861–9.

Article  CAS  PubMed  Google Scholar 

Qiu HZ, Zhang X, Liu SL, Sun XS, Mo YW, Lin HX, Lu ZJ, Guo J, Tang LQ, Mai HQ, et al. M1 stage subdivisions based on (18)F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma. Ther Adv Med Oncol. 2022;14:17588359221118785.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Xu T, Qiu X, Xie S, You Z, Hu Y, Zheng Y, Liang Z, Huang C, Chen T, et al. Selectively recommend (18)F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas. Radiat Oncol. 2021;16(1):229.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Kong Z, Xiang Y, Zheng R, Liu S. The role of PET/CT in radiotherapy for nasopharyngeal carcinoma. Front Oncol. 2022;12:1017758.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang LL, Guo R, Zhang N, Deng B, Chen L, Cheng ZB, Huang J, Hu WH, Huang SH, Luo WJ, et al. Effect of Radiotherapy alone vs Radiotherapy with Concurrent Chemoradiotherapy on Survival without Disease Relapse in patients with low-risk nasopharyngeal carcinoma. A Randomized Clinical Trial. JAMA. 2022;328(8):728–36.

Article  PubMed  PubMed Central  Google Scholar 

Pan JJ, Ng WT, Zong JF, Chan LL, O’Sullivan B, Lin SJ, Sze HC, Chen YB, Choi HC, Guo QJ, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122(4):546–58.

Article  PubMed  Google Scholar 

Wei J, Pei S, Zhu X. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: a meta-analysis. Oral Oncol. 2016;52:11–7.

Article  PubMed  Google Scholar 

Li Z, Li Y, Li N, Shen L. Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: an update evidence from 44 studies. Cancer Med. 2019;8(1):67–79.

Article  CAS  PubMed  Google Scholar 

OuYang PY, Liu ZQ, Lin QG, He Y, Guo ZX, Yao WY, Xu SK, Peng QH, Xiao SM, Li J, et al. Benefit of [(18)F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2023;50(3):881–91.

Article  CAS  PubMed  Google Scholar 

Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47(5):885–95.

PubMed  Google Scholar 

Zhao Q, Dong A, Cui C, Ou Q, Ruan G, Zhou J, Tian L, Liu L, Ma H, Li H. MRI-Based metastatic nodal number and Associated Nomogram Improve Stratification of Nasopharyngeal Carcinoma patients: potential indications for individual induction chemotherapy. J Magn Reson Imaging. 2022.

Huang L, Sim AYL, Wu Y, Liang Z, Li K, Du Y, Ong EHW, Tan HQ, Wee JTS, Xie Y, et al. Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma. Ther Adv Med Oncol. 2020;12:1758835920970050.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Tang S, Chen Z, Wang G, Shen H, Zhou Y, Wang H, Fan W, Liang D, Hu Y, et al. TG-Net: combining transformer and GAN for nasopharyngeal carcinoma tumor segmentation based on total-body uEXPLORER PET/CT scanner. Comput Biol Med. 2022;148:105869.

Article  PubMed  Google Scholar 

You R, Zou X, Wang SL, Jiang R, Tang LQ, Zhang WD, Li L, Zhang MX, Shen GP, Guo L, et al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system. Eur J Cancer. 2015;51(13):1771–9.

Article  PubMed  Google Scholar 

Liu Q, Sun X, Li H, Zhou J, Gu Y, Zhao W, Li H, Yu H, Wang D. Types of Transnasal Endoscopic Nasopharyngectomy for recurrent nasopharyngeal carcinoma: Shanghai EENT Hospital Experience. Front Oncol. 2020;10:555862.

Article  PubMed  Google Scholar 

Li W, Liu Q, Xu H, Wang H, Zhang H, Liu Q, Wang J, Hu L, Li H, Sun X, et al. Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma. Head Neck. 2023;45(2):355–64.

Article  CAS  PubMed  Google Scholar 

Sun XS, Liang YJ, Jia GD, Liu SL, Liu LT, Guo SS, Sun R, Luo DH, Chen QY, Tang LQ, et al. Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma. Oral Oncol. 2020;106:104711.

Article  CAS  PubMed  Google Scholar 

Dongxiang W, Liting L, Yujing L, Meijuan L, Shanshan G, Longbin X, Yanzhou C, Meiling C, Kang N, Haiqiang M et al. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [(18)F]FDG PET/CT parameters. Eur Radiol. 2022.

Yan W, Sun C, Ou X, Hu C. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy. Cancer Imaging. 2023;23(1):21.

Article  PubMed  PubMed Central  Google Scholar 

Lin HC, Chan SC, Cheng NM, Liao CT, Hsu CL, Wang HM, Lin CY, Chang JT, Ng SH, Yang LY, et al. Pretreatment (18)F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncol. 2020;104:104628.

Article  CAS  PubMed  Google Scholar 

Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli NA, Bossi P, Alfieri S, Serafini G, Colombo CB, Cicchetti A, et al. Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy. Radiol Med. 2019;124(5):414–21.

Article  PubMed  Google Scholar 

Kulanthaivelu R, Kohan A, Hinzpeter R, Liu ZA, Hope A, Huang SH, Waldron J, O’Sullivan B, Ortega C, Metser U, et al. Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma. Front Oncol. 2022;12:952763.

Article  CAS  PubMed  PubMed Central  Google Scholar